Stockscreener 앱 받기
17.31
1.09%
-0.19
전일 마감가:
$17.50
열려 있는:
$17.64
하루 거래량:
2.18M
Relative Volume:
0.73
시가총액:
$4.12B
수익:
$474.17M
순이익/손실:
$208.93M
주가수익비율:
20.38
EPS:
0.8493
순현금흐름:
$65.61M
1주 성능:
-3.57%
1개월 성능:
-9.70%
6개월 성능:
-2.15%
1년 성능:
+4.09%
1일 변동 폭
$17.20
$17.67
1주일 범위
$16.24
$18.34
52주 변동 폭
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
ADMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
17.31 | 4.16B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
Will ADMA Biologics Inc outperform small cap indexesJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Retail Trends: Should I add ADMA Biologics Inc stock to my portfolio2025 Price Action Summary & Safe Capital Investment Plans - baoquankhu1.vn
ADMA Biologics reports preliminary 2025 results, ups 2026 outlook - MSN
Liquidity Mapping Around (ADMA) Price Events - Stock Traders Daily
ADMA Biologics, Inc. (ADMA): A Bull Case Theory - Finviz
ADMA Biologics: Business Update And My Price Target (NASDAQ:ADMA) - Seeking Alpha
Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - sharewise.com
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - sharewise.com
Breakout Zone: Whats the beta of ADMA Biologics Inc stock2025 Key Lessons & Safe Entry Momentum Stock Tips - baoquankhu1.vn
ADMA’s Upgraded Multi‑Year Revenue Targets Might Change The Case For Investing In ADMA Biologics (ADMA) - Sahm
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook - sharewise.com
How ADMA’s Multi‑Year Revenue Targets And Margin Push At ADMA Biologics (ADMA) Has Changed Its Investment Story - Yahoo Finance
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.7%Should You Sell? - MarketBeat
A Look At ADMA Biologics (ADMA) Valuation After Raised Guidance And New Long Term Growth Targets - Yahoo Finance
A Look At ADMA Biologics (ADMA) Valuation After New 2025–2027 Guidance And SG-001 Progress - Sahm
ADMA Biologics Highlights $510M+ 2025 Revenue, Raises 2027 Outlook at JPM Healthcare Conference - MarketBeat
Is ADMA Biologics (ADMA) Still Attractive After Recent Share Price Pullback - Yahoo Finance
ADMA Biologics Updates 2025, 2026 Revenue Outlook; 2027 Guidance Issued - marketscreener.com
ADMA Biologics (ADMA) Projects Strong Revenue Growth Through 202 - GuruFocus
ADMA Projects Strong Growth Momentum Heading Into 2026 - GuruFocus
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update - The Manila Times
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides ... - Bluefield Daily Telegraph
Infection-fighting drug data powers ADMA Biologics’ big growth plans - Stock Titan
ADMA Biologics Inc (ADMA) Investor Outlook: Exploring a 42.99% Potential Upside in Biotech - DirectorsTalk Interviews
Peregrine Capital Management LLC Purchases 73,868 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics raises FY25 revenue view to at least $510M from at least $500M - MSN
Can ADMA Biologics Inc. stock beat analyst upgrades2025 Earnings Impact & Proven Capital Preservation Tips - Улправда
ADMA Biologics Sees Unusually High Options Volume (NASDAQ:ADMA) - MarketBeat
Will ADMA Biologics Inc. stock gain from lower inflationWeekly Trade Report & Risk Managed Investment Entry Signals - ulpravda.ru
ADMA Biologics IncCommon Stock (NQ:ADMA) - FinancialContent
What momentum indicators show for ADMA Biologics Inc. stock2025 Momentum Check & Weekly High Return Opportunities - ulpravda.ru
Bear Alert: Can ADMA Biologics Inc. stock sustain free cash flow growth2025 Macro Impact & Daily Risk Controlled Trade Plans - ulpravda.ru
How ADMA Biologics Inc. stock valuations compare to rivalsDividend Cut Warnings & Fast Profit Trading Tips - Улправда
Published on: 2026-01-07 18:06:07 - ulpravda.ru
Nicholas Investment Partners, LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus
2026 world cup team news comparison: Will ADMA Biologics Inc. stock outperform growth indexes2026 world cup usa national team semifinals goalkeepers counter attacking tactical prediction preview - Улправда
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - Yahoo Finance
A Look At ADMA Biologics (ADMA) Valuation As J.P. Morgan Healthcare Conference Presentation Nears - Sahm
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 - The Manila Times
Why (ADMA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Allspring Global Investments Holdings LLC Sells 1,772,112 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Sold by Calamos Advisors LLC - MarketBeat
Does Kizi Apparels Limited Have a Competitive Advantage in Its SectorREITs Market Trends & Free Popular Stock Picks Selection - earlytimes.in
ADMA Biologics Earnings Notes - Trefis
ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade - ts2.tech
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Motley Fool
Harbor Capital Advisors Inc. Buys Shares of 59,801 ADMA Biologics Inc $ADMA - MarketBeat
Rice Hall James & Associates LLC Has $4.75 Million Stake in ADMA Biologics Inc $ADMA - MarketBeat
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet - MSN
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
High Growth Tech Stocks To Watch In US December 2025 - simplywall.st
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adma Biologics Inc 주식 (ADMA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Dec 15 '25 |
Sale |
19.79 |
21,000 |
415,590 |
2,007,850 |
| Grossman Adam S | President and CEO |
Nov 19 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,034,850 |
| Grossman Adam S | President and CEO |
Nov 19 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,013,850 |
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,040,850 |
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,019,850 |
4.73%
0.92%
자본화:
|
볼륨(24시간):